Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study
Journal of Health Economics and Outcomes Research (2025)
Hassan Karami; Shideh Rafati; Maryam Shiri; Ali Mouseli; Hedayat Salari; Amin Ghanbarnejad; Mitra Mowrouzpour; Fatemeh Noroozian; Ali Alizadeh; Fatemeh Asadi; Narges Salehi
Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study
Journal of Health Economics and Outcomes Research 12(2) (2025)
Hassan Karami; Shideh Rafati; Maryam Shirvani Shiri; Ali Mouseli; Hedayat Salari; Amin Ghanbarnejad; Mitra Nowrouzpour; Fatemeh Noroozian; Ali Alizadeh; Fatemeh Asadi; Narges Salehi
Estado actual de la epidemiología, diagnóstico, tratamiento y control de la hepatitis C
Ciencia, Tecnología y Salud 4(1) (2017)
Patricia Velez-Moller
Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran
BMC Health Services Research 25(1) (2025)
Hassan Karami; Amin Ghanbarnejad; Mitra Nowrouzpour; Ali Mouseli; Reihaneh Taheri Kondar; Maryam Shirvani Shiri; Farbod Ebadi Fard Azar
The role of insurance providers in supporting treatment and management of hepatitis C patients
BMC Health Services Research 19(1) (2019)
Masoud Behzadifar; Hasan Abolghasem Gorji; Aziz Rezapour; Meysam Behzadifar; Nicola Luigi Bragazzi
Economic Burden of Inflammatory Bowel Disease in Shiraz, Iran
Archives of Iranian Medicine 26(1) (2023)
Leila Rahmati; Alireza Mooghali; Seyed Mohammad Hosein Kamani; Fatemeh Zare; Hassan Askari; Ali Reza Safarpour
Elimination and Control of Viral Hepatitis B and C Infections Possible With Greater Attention to High Risk Groups
Archives of Clinical Infectious Diseases 12(4) (2017)
Seyed Moayed Alavian
Impact of newer direct-acting antiviral drugs based on quality-adjusted life years
Perspectives in Clinical Research 12(2) (2021)
Bhavya H. Vyas; Nishita H. Darji; Devang A. Rana; Kaushal Y. Vyas; Supriya D. Malhotra
Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis
Health Research Policy and Systems 17(1) (2019)
Masoud Behzadifar; Hasan Abolghasem Gorji; Aziz Rezapour; Alireza Rezvanian; Nicola Luigi Bragazzi; Soudabeh Vatankhah
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
Turkish Journal of Gastroenterology 31(4) (2020)
Bilgehan Aygen; Neşe Demirtürk; Orhan Yıldız; Mustafa Kemal Çelen; İlhami Çelik; Şener Barut; Onur Ural; Ayşe Batırel; Reşit Mıstık; Funda Şimşek; Ali Asan; Gülden Ersöz; Nesrin Türker; Hüseyin Bilgin; Sami Kınıklı; Faruk Karakeçili; Gökmen Zararsız
Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies
Journal of Viral Hepatitis 31(9) (2024)
SeyedehFatemeh Mousavi; Maryam Alavi; Alireza Delavari; Hossein Poustchi; Zahra Mohammadi; Reza Malekzadeh
Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS)
BMC Research Notes 14(1) (2021)
Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Sara Yeganeh; Masood Sepehrimanesh; Mohammad Fathalipour
The Economic Burden of Viral hepatitis C infection at various stages of the disease in District Mardan, Pakistan
Pakistan BioMedical Journal (2022)
Sajjad Khan; Misbah Nosheen
Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme
International Journal of Clinical Pharmacy 43(4) (2020)
Salamat Ali; Tofeeq Ur-Rehman; Mashhood Ali; Sayeed Haque; Faisal Rasheed; Eleri Lougher; Muhammad Sarfraz Nawaz; Vibhu Paudyal
Non-healthcare costs of hepatitis C: a systematic review
Expert Review of Gastroenterology & Hepatology 12(1) (2017)
Natàlia Pascual-Argente; Jaume Puig-Junoy; Anna Llagostera-Punzano
Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study
Therapeutic Apheresis and Dialysis 25(2) (2020)
Shahab Mahmoudvand; Somayeh Shokri; Azarakhsh Azaran; Seyed S. Seyedian; Manoochehr Makvandi; Habibollah Mirzaei; Sheida B. Sheikhrobat
Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China
Hepatitis Monthly 20(3) (2020)
Dangui Zhang; Xubin Zhang; Lu Xu; D. Lorne Tyrrell; Michael Houghton; William Ba-Thein
Evaluation of Direct Acting Antivirals Efficiency in Turkish Patients with Chronic Hepatitis C Under Strict Rules
Hepatitis Monthly In Press(In Press) (2019)
Figen Sarıgul; Murat Sayan; Ulku User; Nefise Oztoprak
Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus
Hepatitis Monthly In Press(In Press) (2019)
Meryem Güvenir; Emrah Guler; Deren Oygar; Ahmet Behlul; Kaya Suer
Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia
Hepatitis Monthly 18(1) (2018)
Ligita Jancoriene; Katazyna Polubenko; Edita Kazenaite; Arida Buivydiene; Jolita Jakutiene; Ieva Tolmane; Agita Jeruma; Daiva Radzisauskiene; Evelina Mockiene; Arvydas Ambrozaitis
The Estimation of Economic Burden of Hepatitis B Virus Infection in Iran
Hepatitis Monthly 17(1) (2017)
Mehdi Mohammadzadeh; Behnaz Fattahi; Tayebeh Ghari
Socio-economic assessments of Hepatitis C Virus infection: Evidence from Vehari district of Pakistan
Archives of Hepatitis Research (2021)
Ahmed Dilshad; Shakeel Muhammad; Tariq Bilal; Mahmood Tariq
MDR1 gene C3435T polymorphism in chronic hepatitis C patients
Microbial Pathogenesis 114 (2018)
Mehdi Parsa Nahad; Manoochehr Makvandi; Ali Teimoori; Shahram Jalilian; Gholam Abbas Kayedani; Sara Mahmoodi
Prevalence of HBV, HCV, and HIV Infections among Patients Undergoing Hemodialysis in Fasa, Iran: A Six-Year Follow-up Study
Middle East Journal of Digestive Diseases 14(3) (2022)
Seyedeh Azra Shamsdin; Mohamad Reza Fatahi; Ali Reza Ansari; Ali Reza Safarpour
Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
Viral Hepatitis Journal 29(3) (2023)
Ayla Doğrugörün; Elif Doyuk Kartal; Saygın Nayman Alpat
The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection
Indian Journal of Medical Microbiology 35(2) (2017)
Shahram Jalilian; Seyed Mahmoud Latifi; Manoochehr Makvandi; Ali Teimoori; Azarakhsh Azaran; Mehdi Parsanahad; Gholamabas Kayedani
Economic Burden of Hepatitis C Infection
Clinics in Liver Disease 21(3) (2017)
Maria Stepanova; Zobair M. Younossi
Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review
PharmacoEconomics 38(9) (2020)
T. Joseph Mattingly; Bryan L. Love; Bilal Khokhar
Sofosbuvir based therapy in Hepatitis C patients with and without cirrhosis: Is there difference?
Pakistan Journal of Medical Sciences 33(1) (2017)
Shahid Sarwar; Anwaar Ahmad Khan